Last updated on November 2017

A trial comparing cardiovascular safety of insulin degludec versus insulin glargine in subjects with type 2 diabetes at high risk of cardiovascular events.


Brief description of study

A trial comparing cardiovascular safety of insulin degludec versus insulin glargine in subjects with type 2 diabetes at high risk of cardiovascular events.

Detailed Study Description

The primary objective is to confirm the cardiovascular safety of insulin degludec compared to that of insulin glargine.

Clinical Study Identifier: TX81474

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Baylor Scott & White Research ...

Baylor Scott & White Research Institute
Dallas, TX USA
  Connect »